Amylyx Pharmaceuticals, Inc. (AMLX) SEC filings
AMLX SEC filings moved a median of -0.82% by the close. AMLX SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the AMLX overview →
60 measured AMLX SEC filing events.
Where these AMLX SEC filings landedvs 60 measured AMLX SEC filing reactions
| Middle 50% of AMLX SEC filing reactions | -4.65% to +6.37% |
|---|---|
| Median reaction (to close) | -0.82% |
| Measured reactions | 60 |
Point-in-time · zero look-ahead
Half of the 60 AMLX SEC filing events with a measured close landed between -4.65% and +6.37%; 48% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Amylyx Pharmaceuticals, For: Sep 01 | SEC filing · Form 8-K | +1.21% | -3.28% | |
| Form 8-K Amylyx Pharmaceuticals, For: Aug 19 | SEC filing · Form 8-K | +0.06% | -3.18% | |
| Form 8-K Amylyx Pharmaceuticals, For: Aug 18 | SEC filing · Form 8-K | +1.25% | +17.03% | |
| Form 10-Q Amylyx Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | +10.13% | +12.98% | |
| Form 8-K Amylyx Pharmaceuticals, For: Aug 06 | SEC filing · Form 8-K | +10.13% | +12.98% | |
| Form 8-K Amylyx Pharmaceuticals, For: Jun 04 | SEC filing · Form 8-K | +0.56% | -6.53% | |
| Form 10-Q Amylyx Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | -1.21% | -4.88% | |
| Form 8-K Amylyx Pharmaceuticals, For: May 07 | SEC filing · Form 8-K | -1.21% | -4.88% | |
| Form ARS Amylyx Pharmaceuticals, For: Dec 31 | SEC filing · Form ARS | +0.83% | -1.14% | |
| Form DEF 14A Amylyx Pharmaceuticals, For: Jun 04 | SEC filing · Form DEF | +0.83% | -1.14% | |
| Form DEFA14A Amylyx Pharmaceuticals, | SEC filing · Form DEFA14A | +0.83% | -1.14% | |
| Form 8-K Amylyx Pharmaceuticals, For: Mar 24 | SEC filing · Form 8-K | +1.05% | +2.09% | |
| Form 10-K Amylyx Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | -4.05% | -8.49% | |
| Form 8-K Amylyx Pharmaceuticals, For: Mar 03 | SEC filing · Form 8-K | -4.05% | -8.49% | |
| Form S-3ASR Amylyx Pharmaceuticals, | SEC filing · Form S-3ASR | -4.05% | -8.49% | |
| Form S-8 Amylyx Pharmaceuticals, | SEC filing · Form S-8 | -0.92% | +6.96% | |
| Form 8-K Amylyx Pharmaceuticals, For: Jan 08 | SEC filing · Form 8-K | -1.18% | -0.51% | |
| Form 10-Q Amylyx Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | -3.66% | -4.01% | |
| Form 8-K Amylyx Pharmaceuticals, For: Nov 06 | SEC filing · Form 8-K | -3.66% | -4.01% | |
| Form 8-K Amylyx Pharmaceuticals, For: Sep 09 | SEC filing · Form 8-K | -0.09% | +2.07% | |
| Form 8-K Amylyx Pharmaceuticals, For: Aug 27 | SEC filing · Form 8-K | +0.54% | +2.50% | |
| Form 10-Q Amylyx Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | -0.63% | -2.00% | |
| Form 8-K Amylyx Pharmaceuticals, For: Aug 07 | SEC filing · Form 8-K | -0.63% | -2.00% | |
| Form 8-K Amylyx Pharmaceuticals, For: Jun 05 | SEC filing · Form 8-K | +0.10% | +6.17% | |
| Form 10-Q Amylyx Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -10.37% | |
| Form 8-K Amylyx Pharmaceuticals, For: May 08 | SEC filing · Form 8-K | +0.00% | -10.37% | |
| Form ARS Amylyx Pharmaceuticals, For: Dec 31 | SEC filing · Form ARS | +0.00% | +3.76% | |
| Form DEF 14A Amylyx Pharmaceuticals, For: Jun 05 | SEC filing · Form DEF | +0.00% | +3.76% | |
| Form DEFA14A Amylyx Pharmaceuticals, | SEC filing · Form DEFA14A | +0.00% | +3.76% | |
| Form EFFECT Amylyx Pharmaceuticals, | SEC filing · Form EFFECT | +0.00% | +2.38% | |
| Form 10-K Amylyx Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | -0.71% | +7.50% | |
| Form 8-K Amylyx Pharmaceuticals, For: Mar 04 | SEC filing · Form 8-K | -0.71% | +7.50% | |
| Form POSASR Amylyx Pharmaceuticals, | SEC filing · Form POSASR | -0.71% | +7.50% | |
| Form S-3 Amylyx Pharmaceuticals, | SEC filing · Form S-3 | -0.71% | +7.50% | |
| Form S-8 Amylyx Pharmaceuticals, | SEC filing · Form S-8 | +1.33% | +11.63% | |
| Form 8-K Amylyx Pharmaceuticals, For: Jan 10 | SEC filing · Form 8-K | -3.74% | -8.62% | |
| Form 8-K Amylyx Pharmaceuticals, For: Dec 30 | SEC filing · Form 8-K | +1.44% | +0.26% | |
| Form 10-Q Amylyx Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +3.17% | +9.00% | |
| Form 8-K Amylyx Pharmaceuticals, For: Nov 07 | SEC filing · Form 8-K | +3.17% | +9.00% | |
| Form 8-K Amylyx Pharmaceuticals, For: Oct 17 | SEC filing · Form 8-K | -14.29% | -5.08% | |
| Form 10-Q Amylyx Pharmaceuticals, For: Jun 30 | SEC filing · Form 10-Q | -7.30% | -5.76% | |
| Form 8-K Amylyx Pharmaceuticals, For: Aug 08 | SEC filing · Form 8-K | -7.30% | -5.76% | |
| Form 8-K Amylyx Pharmaceuticals, For: Jul 09 | SEC filing · Form 8-K | +1.22% | +22.48% | |
| Form 8-K Amylyx Pharmaceuticals, For: Jun 21 | SEC filing · Form 8-K | +2.50% | +1.67% | |
| Form 8-K Amylyx Pharmaceuticals, For: Jun 06 | SEC filing · Form 8-K | -1.16% | +2.31% | |
| Form 10-Q Amylyx Pharmaceuticals, For: Mar 31 | SEC filing · Form 10-Q | -1.69% | +2.72% | |
| Form 8-K Amylyx Pharmaceuticals, For: May 09 | SEC filing · Form 8-K | -1.69% | +2.72% | |
| Form ARS Amylyx Pharmaceuticals, For: Dec 31 | SEC filing · Form ARS | -0.51% | -4.57% | |
| Form DEF 14A Amylyx Pharmaceuticals, For: Jun 06 | SEC filing · Form DEF | -0.51% | -4.57% | |
| Form DEFA14A Amylyx Pharmaceuticals, | SEC filing · Form DEFA14A | -0.51% | -4.57% | |
| Form 8-K Amylyx Pharmaceuticals, For: Apr 10 | SEC filing · Form 8-K | +1.15% | -5.38% | |
| Form 8-K Amylyx Pharmaceuticals, For: Apr 03 | SEC filing · Form 8-K | +2.65% | -2.25% | |
| Form 8-K Amylyx Pharmaceuticals, For: Mar 14 | SEC filing · Form 8-K | -2.32% | -6.49% | |
| Form 8-K Amylyx Pharmaceuticals, For: Mar 08 | SEC filing · Form 8-K | +0.52% | +15.07% | |
| Form 10-K Amylyx Pharmaceuticals, For: Dec 31 | SEC filing · Form 10-K | +6.77% | +12.02% | |
| Form 8-K Amylyx Pharmaceuticals, For: Feb 22 | SEC filing · Form 8-K | +6.77% | +12.02% | |
| Form S-8 Amylyx Pharmaceuticals, | SEC filing · Form S-8 | +0.69% | -5.77% | |
| Form 8-K Amylyx Pharmaceuticals, For: Dec 07 | SEC filing · Form 8-K | +4.44% | +3.57% | |
| Form 10-Q Amylyx Pharmaceuticals, For: Sep 30 | SEC filing · Form 10-Q | +0.79% | -2.70% | |
| Form 8-K Amylyx Pharmaceuticals, For: Nov 09 | SEC filing · Form 8-K | +0.79% | -2.70% |
Keep exploring
More AMLX: earnings → · analyst actions → · AMLX overview →